Is Elevation Oncology, Inc. (ELEV) a Buy, Sell, or Hold?
NASDAQ : ELEV
Elevation Oncology, Inc. — Competitors
$0.365 USD
-$0.01 (-2.12%)
- Volume
- 4.82M
- Average Volume
- 1.35M
- Market Capitalization
- $21.63M
- P/E Ratio
- -0.47
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $3.09
- Year Low
- $0.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.21
ELEV vs. The Competition
| Properties | ELEV | ANPC | DOMH | KA |
|---|---|---|---|---|
| Market Cap | $21.63M | $26.97M | $45.58M | $7.05M |
| Shares Outstanding | $59.25M | $6.27M | $16.11M | $12.26M |
| P/E Ratio | -0.47 | -0.54 | -1.32 | -0.4 |
| EPS | -0.78 | -54.18 | -2.62 | -1.42 |
| Day Low | 0.365 | 4.25 | 2.79 | 0.56 |
| Day High | 0.365 | 4.63 | 2.89 | 0.825 |
| Year Low | 0.221 | 2.6 | 2.69 | 0.3339 |
| Year High | 3.09 | 11.99 | 8.4 | 5.39 |
| Average Price 50 | 0.35436 | 5.045148 | 3.1472 | 0.649607 |
| Average Price 200 | 0.48923 | 5.348831 | 3.84975 | 1.1191639 |
| Volume | 4.82M | 35704 | 27193 | 480.68K |
| Average Volume | - | - | - | - |